Oritavancin(OC)
Catalog No: 42510
CAS Number: 192564-14-0
Purity: 98% by HPLC at 254nm
Oritavancin (INN, also known as LY333328, Orbactiv) is a novel semisynthetic glycopeptide antibiotic for the treatment of serious Gram-positive bacterial infections. Its chemical structure as a lipoglycopeptide is similar to vancomycin.In August 2014, the United States FDA approved oritavancin for treatment of skin infections.
For research use only. We do not sell to patients.
Chemical Information
| Name | Oritavancin(OC) |
|---|---|
| Iupac Chemical Name | (4R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-��-L-arabinohexopyranosyl)-N3-(p-(p-chlorophenyl)benzyl)vancomycin |
| Synonyms | Oritavancin Diphosphate;LY333328;LY-333328;Orbactiv |
| Molecular Formula | C86H103Cl3N10O34P2 |
| Molecular Weight | 1989.09 |
| InChiKey | |
| InChi | |
| CAS Number | 192564-14-0 |
| Related CAS |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | white solid |
|---|---|
| Purity | 98% by HPLC at 254nm |
| Storage | 3 years -20ºCpowder 6 months-80ºCin solvent |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature. |
| HS Code |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Not available
Chemical Structure
